Penn Medicine Provider
Dermatology
Lisa K. Pappas-Taffer, MD
5.0
(615)
Accepting new patients
Sees patients age 18 and up
Penn Dermatology Perelman
View 1 additional location
Schedule onlineCall 215-662-2737

About me

  • Medical Director of Penn Dermatology at Bucks County
  • Associate Professor of Clinical Dermatology

Education and training

  • Medical School: Wayne State University School of Medicine
  • Residency: NYU Langone Medical Center
  • Residency: Brown University, Rhode Island Hospital

What my patients think about me

Average Rating
5.0

619 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
5.0
5.0
excellent care
May 2025
5.0
5.0
excellent dr
May 2025
5.0
5.0
very thorough.
May 2025
5.0
5.0
efficient and knowledgeable

Insurance accepted

My Locations

Learn about location
Learn about location

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Pappas-Taffer is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Tuohy S, Wachuku C, Wang YA, Prasad A, Samimi SS, Pappas-Taffer LK, Haun PL, Wang LL. Cutaneous mantle cell lymphoma presenting as a diffuse morbilliform rash: A case report. , SAGE Open Med Case Report., 11: 2023

Weiner DM, Clark AK, Bhansali RS, Pappas-Taffer L, Barta SK, Villasenor-Park J, Haun PL, Vittorio CC, Rook AH, Kim EJ, Samimi SS Usage and safety of topical tacrolimus in patients with mycosis fungoides , Clin Exp Dermatol , 47(6): 2022,1200-1201

David M Weiner, Ashley K Clark, Rahul S Bhansali, Lisa Pappas-Taffer, Stefan K Barta, Jennifer Villasenor-Park, Paul L Haun, Carmela C Vittorio, Alain H Rook, Ellen J Kim, Sara S Samimi Usage and Safety of Topical Tacrolimus in Mycosis Fungoides , Clin Exp Dermatol , 47(6): 2022,1200-1201

Yan D, Gaffney R, Krain R, Keyes E, Concha J, Feng R, Schulz S, Pappas-Taffer L, Borucki R, Ravishanar A, Bax C, Okawa J, Werth V A prospective cohort study comparing the performance of interferon gamma release assays in autoimmune skin diseases , J Am Acad Derm, 86(4): 2022,948-949

Ravishankar A, Bax CE, Grinnell M, Yan D, Concha JS, Pappas-Taffer L, Shields B, Dany M, Clark AK, Feng R, Okawa J, Werth VP Frequency of immunostimulatory herbal supplement use among patients with autoimmune skin disease , J Am Acad Dermatol, S0190-9622(22): 2022,00012-3

Bax CE, Maddukuri S, Ravishankar A, Pappas-Taffer L, Werth VP Environmental Triggers of Dermatomyositis: A Narrative Review , Ann Transl Med, 9(5): 2021,434

Pei S, Fischer AS, Preciado C, Pappas-Taffer L, Elenitsas R, Rubin AI Firm hyperpigmented papules coalescing into a plaque in an adult female with systemic sclerosis: Challenge (Nodular Scleroderma) , Am J of Dermatopathology, 42(12): 2020 ,e159-e160

Pei S, Fischer AS, Preciado C, Pappas-Taffer L, Elenitsas R, Rubin AI Firm hyperpigmented papules coalescing into a plaque in an adult female with systemic sclerosis: Answer , Am J Dermatopathology, 42(12): 2020,1003

Ravishankar A, Pappas-Taffer L, Werth V Immunostimmulatory Herbal Supplement Use is More Common Among Patients with Dermatomyositis , American College of Rheumatology Annual Meeting: 2020

Yan D, Pappas-Taffer L, Werth V Morphea , Medscape (Available at: http://emedicine.medscape.com/article/1065782-overview) : 2020